Calcium Ionophore Therapy – Oocyte Activation in ICSI
Calcium ionophore therapy is an assisted reproduction technique used to artificially activate oocytes when fertilization fails or does not occur after ICSI.
Things worth knowing about "Calcium ionophore therapy"
Calcium ionophore therapy is an assisted reproduction technique used to artificially activate oocytes when fertilization fails or does not occur after ICSI.
What Is Calcium Ionophore Therapy?
Calcium ionophore therapy, also referred to as assisted oocyte activation (AOA), is a specialized procedure used in reproductive medicine. It is applied when oocytes fail to activate after intracytoplasmic sperm injection (ICSI), resulting in failed fertilization. The term “ionophore” refers to a chemical compound capable of transporting ions – in this case calcium ions (Ca²+) – across cell membranes.
Background: The Role of Calcium in Fertilization
During natural fertilization, the entry of a sperm cell into the oocyte triggers a series of repeated rises in intracellular calcium concentration, known as calcium oscillations. These signals are essential to activate the oocyte from its resting state (metaphase II arrest) and initiate cell division. In certain cases of male infertility – particularly when the sperm protein phospholipase C zeta (PLCζ) is absent or dysfunctional – these calcium signals do not occur, and the oocyte remains unactivated.
When Is Calcium Ionophore Therapy Used?
- Total or partial fertilization failure following ICSI
- Repeated failure to achieve fertilization in previous ICSI cycles
- Severe teratozoospermia (significant abnormalities in sperm morphology)
- Confirmed PLCζ deficiency in the male partner
- Severely reduced sperm motility (asthenozoospermia)
Mechanism of Action
In calcium ionophore therapy, oocytes are briefly exposed to a calcium ionophore solution following ICSI. The most commonly used compounds are A23187 (calcimycin) and ionomycin. These molecules bind extracellular calcium ions and transport them across the oocyte membrane into the cytoplasm. This artificially raises the intracellular calcium concentration, triggering the oocyte activation cascade in a manner similar to natural fertilization.
Step-by-Step Procedure
- ICSI is performed as standard
- Oocytes are briefly incubated in a calcium ionophore solution (typically for 10–15 minutes)
- Oocytes are rinsed and returned to the incubator for further culture
- Fertilization is assessed 16–18 hours later
Efficacy and Scientific Evidence
Several clinical studies and meta-analyses have demonstrated that calcium ionophore therapy can significantly improve fertilization rates in couples with previous total fertilization failure. Reported fertilization rates after ionophore treatment range from 30–60 %, compared to 0 % without activation. Clinical pregnancy rates and live birth rates are also improved in selected patient groups, although long-term outcome data continue to be gathered.
Safety and Potential Risks
Calcium ionophore therapy is generally considered a safe procedure. Available data do not show an increased rate of congenital malformations or chromosomal abnormalities in children born following this treatment. However, further long-term studies are still needed to fully assess the safety profile. As this is an additional intervention within the ICSI process, its use is recommended only in clearly defined clinical indications.
Requirements and Clinical Setting
Calcium ionophore therapy is exclusively performed in specialized reproductive medicine centers (IVF laboratories). Before applying the technique, all other potential causes of fertilization failure – such as technical errors during ICSI or poor oocyte quality – should be excluded. Comprehensive counseling of the couple regarding the partially experimental nature of the procedure and the current state of evidence is mandatory prior to treatment.
References
- Vanden Meerschaut F. et al. (2014): Assisted oocyte activation following ICSI fertilization failure. Reproductive BioMedicine Online, 28(5), 560–571. DOI: 10.1016/j.rbmo.2014.01.008
- Nikiforaki D. et al. (2016): Oocyte activation deficiency: a systematic review. Human Reproduction Update, 22(5), 544–560. DOI: 10.1093/humupd/dmw016
- Murugesu S. et al. (2017): Does the use of calcium ionophore during artificial oocyte activation demonstrate an effect on pregnancy and neonatal outcomes? Human Reproduction, 32(9), 1929–1939. DOI: 10.1093/humrep/dex244
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryCytoprotection stimulation
Fascial myoma
Ubiquinol biosynthesis kinetics
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Calcium ionophore therapy